Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain

Acupuncture in Medicine

Volumn 30, Issue 1, 2012, Pages 53-55

  Kopsky, David J ^a   Hesselink, Jan M Keppel ^a,b  

^a Institute for Neuropathic Pain   (Netherlands)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PALMIDROL; PALMITIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ACUPUNCTURE; ANALGESIA; ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG POTENTIATION; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURALGIA;

ACUPUNCTURE THERAPY; ANALGESIA; ANALGESICS; CHRONIC DISEASE; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURALGIA; PAIN MANAGEMENT; PALMITIC ACIDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA;

EID: 84859732874     PISSN: 09645284     EISSN: None     Source Type: Journal    
DOI: 10.1136/acupmed-2011-010119     Document Type: Article

References (15)

1. Solaro C, Messmer Uccelli M. Pharmacological management of pain in patients with multiple sclerosis. Drugs 2010;70:1245-54
2. Pöllmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008;22:291-324 (Pubitemid 351367440)
3. Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009;374:1252-61
4. Sertel S, Herrmann S, Greten HJ, et al. Additional use of acupuncture to NSAID effectively reduces post-tonsillectomy pain. Eur Arch Otorhinolaryngol 2009;266:919-25
5. Wetzel B, Pavlovic D, Kuse R, et al. The effect of auricular acupuncture on fentanyl requirement during hip arthroplasty: a randomized controlled trial. Clin J Pain 2011;27:262-7
6. Darmani NA, Izzo AA, Degenhardt B, et al. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in infl ammatory and neuro-pathic conditions: review of the available pre-clinica data, and first human studies. Neuropharmacology 2005;48:1154-63 (Pubitemid 40725988)
7. Petrosino S, Iuvone T, Di Marzo V. N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. Biochimie 2010;92:724-7
8. Guida G, de Fabiani A, Lanaia F, et al. La palmitoile-tanolamida (Normast) en el dolor neuropatico cronico por lumbociatalgia de tipo compresivo: estudio clinico multicentrico. Dolor 2010;25:35-42
9. Biasiotta A, La Cesa S, Leone C, et al. Efficacy of palmitoylethanolamide in patients with painful neu-ropathy. A clincial and neurophysiological open study. Preliminary results. Eur J Pain Sup 2010;4:77
10. Assini A, Laricchia D, Pizzo R, et al. P1577: the carpal tunnel syndrome in diabetes: clinica and electrophysiological improvement after treatment with palmitoylethanolamide Eur J Neurol 2010;17:295.
11. Liang LL, Yang JL, Lü N, et al. Synergetic analgesia of propentofylline and electroacupuncture by interrupting spinal glial function in rats. Neurochem Res 2010;35:1780-6
12. Sun S, Cao H, Han M, et al. Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoar-thritis. Brain Res Bull 2008;75:83-93
13. Muccioli GG, Stella N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 2008;54:16-22. (Pubitemid 350299394)
14. Esposito E, Paterniti I, Mazzon E, et al. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun 2011;25:1099-112.
15. Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010;126:56-68